Development and internal validation of simplified predictive scoring (ICU-SEPSA score) for mortality in patients with multidrug resistant infection.

MLA

Sirichayanugul, Taranee, et al. “Development and Internal Validation of Simplified Predictive Scoring (ICU-SEPSA Score) for Mortality in Patients with Multidrug Resistant Infection.” Frontiers in Pharmacology, vol. 13, Aug. 2022, p. 938028. EBSCOhost, https://doi.org/10.3389/fphar.2022.938028.

APA

Sirichayanugul, T., Srisawat, C., Thummakomut, C., Prawang, A., Huynh, N. S., Saokaew, S., Phisalprapa, P., & Kanchanasurakit, S. (2022). Development and internal validation of simplified predictive scoring (ICU-SEPSA score) for mortality in patients with multidrug resistant infection. Frontiers in Pharmacology, 13, 938028. https://doi.org/10.3389/fphar.2022.938028

Chicago

Sirichayanugul, Taranee, Chansinee Srisawat, Chawin Thummakomut, Abhisit Prawang, Nina S Huynh, Surasak Saokaew, Pochamana Phisalprapa, and Sukrit Kanchanasurakit. 2022. “Development and Internal Validation of Simplified Predictive Scoring (ICU-SEPSA Score) for Mortality in Patients with Multidrug Resistant Infection.” Frontiers in Pharmacology 13 (August): 938028. doi:10.3389/fphar.2022.938028.